Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca.
<h4>Background</h4>TGF-β is a pleiotropic cytokine that can have pro- or anti-inflammatory effects depending on the context. Elevated levels of bioactive TGF-β1 in tears and elevated TGF-β1mRNA transcripts in conjunctiva and minor salivary glands of human Sjögren's Syndrome patients...
Guardado en:
Autores principales: | Cintia S De Paiva, Eugene A Volpe, Niral B Gandhi, Xiaobo Zhang, Xiaofen Zheng, John D Pitcher, William J Farley, Michael E Stern, Jerry Y Niederkorn, De-Quan Li, Richard A Flavell, Stephen C Pflugfelder |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/60dc5f26b15249c1a0229a4f9063c6a7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca
por: Koray Gumus, et al.
Publicado: (2008) -
Immune-mediated keratoconjunctivitis sicca in dogs: current perspectives on management
por: Dodi PL
Publicado: (2015) -
A Review of Topical Cyclosporine A Formulations—A Disease-Modifying Agent for Keratoconjunctivitis Sicca
por: Jerkins GW, et al.
Publicado: (2020) -
Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca
por: Sheppard J, et al.
Publicado: (2021) -
Treatment of patients with keratoconjunctivitis sicca with Optive&trade;: results of a multicenter, open-label observational study in Germany
por: Thomas Kaercher, et al.
Publicado: (2008)